IJH Volume 121, Issue 2, February 2025 is now available. February 5, 2025 IJH Volume 121, Issue 2, February 2025 is now available. JSH members can access the full text. Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factors and more!